HIP
UTHR icon

HUB Investment Partners’s United Therapeutics UTHR Stock Holding History

HUB Investment Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-913
Closed -$262K – 935
2025
Q2 		$262K Buy
913
+4
+0.4% +$1.2K 0.01% 550
2025
Q1 		$280K Buy
909
+214
+31% +$73.3K 0.01% 469
2024
Q4 		$245K Sell
695
-165
-19% -$60.6K 0.01% 449
2024
Q3 		$308K Buy
+860
New +$291K 0.01% 374

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

HUB Investment Partners's UTHR Position: Q3 2025 in Review

HUB Investment Partners sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 913 shares — an estimated $262K sold.

HUB Investment Partners first reported a position in UTHR in Q3 2024 and held it in 4 quarters. The position peaked at $308K in Q3 2024. 708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • HUB Investment Partners reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • HUB Investment Partners sold 913 United Therapeutics shares in Q3 2025, an estimated $262K.
  • HUB Investment Partners first reported a position in United Therapeutics in Q3 2024 and held it in 4 quarters.
  • HUB Investment Partners's United Therapeutics position peaked at $308K in Q3 2024.
  • 708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on HUB Investment Partners's 13F filing for Q3 2025, filed 12 Nov 2025.